Indeed, a fusion compound of the cytokine LIGHT conjugated to a homing peptide (vascular targeting peptide or VTP) which delivers LIGHT specifically to angiogenic tumor vessels is such a reagent (95). This evidence concerns the gene TNFSF14 and neoplasm.